Comparative Hemostasis: Animal Models and New Hemostasis Tests

Clinics in Laboratory Medicine

Volumn 31, Issue 1, 2011, Pages 139-159

  Brooks, Marjory B ^a   Stokol, Tracy ^a   Catalfamo, James L ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Animal model; Flow cytometry; Hemostasis; Thromboelastography

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; THROMBIN;

BLOOD CLOTTING; CLASSIFICATION ALGORITHM; ENZYME SYNTHESIS; EXPERIMENTAL MODEL; FLOW CYTOMETRY; GENETIC ENGINEERING; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; THROMBIN TIME; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY;

ANIMALS; FLOW CYTOMETRY; GENETIC ENGINEERING; HEMATOLOGIC TESTS; HEMOSTASIS; MODELS, ANIMAL; PLATELET ACTIVATION; THROMBELASTOGRAPHY; THROMBIN;

EID: 79551486325     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2010.10.009     Document Type: Review

References (76)

1. Mackman N. Tissue-specific hemostasis in mice. Arterioscler Thromb Vasc Biol 2005, 25(11):2273-2281.
2. Furie B., Furie B.C. In vivo thrombus formation. J Thromb Haemost 2007, 5(Suppl 1):12-17.
3. Westrick R.J., Winn M.E., Eitzman D.T. Murine models of vascular thrombosis. Arterioscler Thromb Vasc Biol 2007, 27:2079-2093.
4. Wessler S. Animals models of thrombosis and hemorrhagic diseases 1976, DHEW Pub. No. NIH 76982, U.S. Department of Health, Education and Welfare, Washington, DC.
5. Hau J. Animal models for human diseases. Source book of models for biomedical research 2008, 3-8. Humana Press Inc, Totowa (NJ). P.M. Conn (Ed.).
6. Aoshima K., Asakura H., Yamazaki M., et al. Treatment of disseminated intravascular coagulation (DIC) with all trans retinoic acid in an endotoxin-induced rat model. Semin Thromb Hemost 1998, 24(3):227-231.
7. Bodary P.F., Westrick R.J., Wickenheiser K.J., et al. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA 2002, 287:1706-1709.
8. The Jackson Laboratory Available at:, Accessed September 20, 2010. http://www.jax.org.
9. Hamosh A. John Hopkins University School of Medicine, On-line Mendelian Inheritance in Man, OMIM Available at:, Accessed September 20, 2010. http://www.ncbi.nlm.nih.gov/omim/.
10. Nicholas F. University of Sydney, On-line Mendelian Inheritance in Animals (OMIA) Available at:, Accessed September 20, 2010. http://www.ncbi.nlm.nih.gov/sites/omia.
11. Brooks M. A review of canine inherited bleeding disorders: biochemical and molecular strategies for disease characterization and carrier detection. J Hered 1999, 90(1):112-118.
12. Booth C.J., Brooks M.B., Rockwell S., et al. WAG-F8 rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A. J Thromb Haemost 2010, 8:2472-2477.
13. Wolfe J.H. Gene therapy in large animal models of human genetic diseases. ILAR J 2009, 50(2):107-111.
14. Nichols T.C., Dillow A.M., Franck H.W., et al. Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von Willebrand disease, and factor VII deficiency. ILAR J 2009, 50(2):144-167.
15. Boudreaux M.K., Lipscomb D.L. Clinical, biochemical, and molecular aspects of Glanzmann thrombasthenia in humans and dogs. Vet Pathol 2001, 38:249-260.
16. Trammell R.A., Brooks M., Cox L., et al. Fatal hemorrhagic diathesis associated with mild factor IX deficiency in pl/J mice. Comp Med 2006, 56(5):426-434.
17. Tong C., Li P., Wu N.L., et al. Production of p53 knockout rats by homologous recombination of embyronic stem cells. Nature 2010, 467(7312):211-213.
18. Yang X., Tian X.C., Dai Y., et al. Transgenic farm animals: applications in agriculture and biomedicine. Biotechnol Annu Rev 2000, 5:269-292.
19. Lang M.R., Gihr G., Gawaz M.P., et al. Hemostasis in Danio rerio: is the zebra fish a useful model for platelet research?. J Thromb Haemost 2010, 8:1159-1169.
20. Boudreaux M.K., Schmutz S.M., French P.S. Calcium diacylglycerol guanine nucleotide exchange factor I (CalDAG-GEFI) gene mutations in a thrombopathic Simmental calf. Vet Pathol 2007, 44(6):932-935.
21. Boudreaux M.K., Catalfamo J.L., Klok M. Calcium-diacylglycerol guanine nucleotide exchange factor I gene mutations associated with loss of function in canine platelets. Transl Res 2007, 150(2):81-92.
22. Crittenden J.R., Bergmeier W., Zhang Y., et al. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med 2004, 10(9):982-986.
23. Hoffman M., Monroe D. A cell-based model of hemostasis. Thromb Haemost 2001, 85(6):958-965.
24. Satta N., Toti F., Fressinaud E., et al. Scott syndrome: an inherited defect of the procoagulant activity of platelets. Platelets 1997, 8(2-3):117-124.
25. Brooks M.B., Catalfamo J.L., Brown H.A., et al. A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity. Blood 2002, 99(7):2434-2441.
26. Falati S., Liu Q., Gross P., et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003, 197(11):1585-1598.
27. Boudreaux M.K. Characteristics, diagnosis, and treatment of inherited platelet disorders in mammals. JAMA 2008, 233(8):1251-1259.
28. Shiraishi M., Ogawa H., Ikeda M., et al. Platelet dysfunction in Chediak-Higashi syndrome-affected cattle. J Vet Med Sci 2002, 64(9):751-760.
29. Cifuni S.M., Wagner D.D., Bergmeier W. CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets. Blood 2008, 112(5):1696-1703.
30. Malinin N.L., Zhang L., Choi J., et al. A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med 2009, 15(3):313-318.
31. Boudreaux M.K., Wardrop K.J., Kiklevich V., et al. A mutation in the canine Kindlin-3 gene associated with increased bleeding risk and susceptibility to infections. Thromb Haemost 2010, 103(2):475-477.
32. Toomey J.R., Kratzer K.E., Lasky N.M., et al. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996, 88(5):1583-1587.
33. Rosen E.D., Chan J.C., Idusogie E., et al. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature 1997, 390(6657):290-294.
34. Perry D.J. Factor VII deficiency. Br J Haematol 2002, 118(3):689-700.
35. Callan M.B., Aljamali M.N., Margaritis P., et al. A novel missense mutation responsible for factor VII deficiency in research Beagle colonies. J Thromb Haemost 2006, 4(12):2616-2622.
36. Soute B.A., Ulrich M.M., Watson A.D., et al. Congenital deficiency of all vitamin K-dependent blood coagulation factors due to a defective vitamin K-dependent carboxylase in Devon rex cats. Thromb Haemost 1992, 68(5):521-525.
37. Johnson J.S., Soute B.A., Olver C.S., et al. Defective gamma-glutamyl carboxylase activity and bleeding in Rambouillet sheep. Vet Pathol 2006, 43(5):726-732.
38. Satta N., Toti F., Feugeas O., et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 1994, 153(7):3245-3255.
39. Piccin A., Murphy W.G., Smith O.P. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2006, 21:157-171.
40. Ponczek M.B., Gailani D., Doolittle R.F. Evolution of the contact phase of vertebrate blood coagulation. J Thromb Haemost 2008, 6(11):1876-1883.
41. Kier A.B., Bresnahan F.J., White F.J., et al. The inheritance pattern of factor XII (Hageman) deficiency in domestic cats. Can J Comp Med 1980, 44:309-314.
42. Renne T., Pozgajova M., Gruner S., et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005, 202(2):271-281.
43. Segers O., Castoldi E. Factor V Leiden and activated protein C resistance. Adv Clin Chem 2009, 49:121-157.
44. Ganter M.T., Hofer C.K. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008, 106(5):1366-1375.
45. Luddington R.J. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005, 27(2):81-90.
46. Rivard G.E., Brummel-Ziedins K.E., Mann K.G., et al. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost 2005, 3(9):2039-2043.
47. Camenzind V., Bombeli T., Seifert B., et al. Citrate storage affects Thrombelastograph analysis. Anesthesiology 2000, 92(5):1242-1249.
48. Johansson P.I., Bochsen L., Andersen S., et al. Investigation of the effect of kaolin and tissue factor-activated citrated whole blood, on clot forming variables, as evaluated by thromboelastography. Transfusion 2008, 48(11):2377-2383.
49. Thalheimer U., Triantos C.K., Samonakis D.N., et al. A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood. Blood Coagul Fibrinolysis 2008, 19(6):495-501.
50. Nielsen V.G., Steenwyk B.L., Gurley W.Q., et al. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro. J Heart Lung Transplant 2006, 25(6):653-663.
51. Sorensen B., Ingerslev J. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2004, 2(1):102-110.
52. Nielsen V.G. Corn trypsin inhibitor decreases tissue-type plasminogen activator-mediated fibrinolysis of human plasma. Blood Coagul Fibrinolysis 2009, 20(3):191-196.
53. Hobson A.R., Agarwala R.A., Swallow R.A., et al. Thrombelastography: current clinical applications and its potential role in interventional cardiology. Platelets 2006, 17(8):509-518.
54. Otto C.M., Rieser T.M., Brooks M.B., et al. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000, 217(10):1500-1504.
55. Wiinberg B., Jensen A.L., Johansson P.I., et al. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 2008, 22(2):357-365.
56. Siller-Matula J.M., Plasenzotti R., Spiel A., et al. Interspecies differences in coagulation profile. Thromb Haemost 2008, 100(3):397-404.
57. Baglin T. The measurement and application of thrombin generation. Br J Haematol 2005, 130(5):653-661.
58. Hemker H.C., Al Dieri R., De Smedt E., et al. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 2006, 96(5):553-561.
59. Chantarangkul V., Clerici M., Bressi C., et al. Standardization of the endogenous thrombin potential measurement: how to minimize the effect of residual platelets in stored plasma. Br J Haematol 2004, 124(3):355-357.
60. Berckmans R.J., Neiuwland R., Boing A.N., et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001, 85(4):639-646.
61. Lippi G., Salvagno G.L., Montagnana M., et al. Reliability of the thrombin-generation assay in frozen-thawed platelet-rich plasma. Clin Chem 2006, 52(9):1827-1828.
62. van Veen J.J., Gatt A., Makris M. Thrombin generation testing in routine clinical practice: are we there yet?. Br J Haematol 2008, 142(6):889-903.
63. Chantarangkul V., Clerici M., Bressi C., et al. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Haematologica 2003, 88(5):547-554.
64. Kimura A., Ikeo K., Nonaka M. Evolutionary origin of the vertebrate blood complement and coagulation systems inferred from liver EST analysis of lamprey. Dev Comp Immunol 2009, 33(1):77-87.
65. Ault K.A. The clinical utility of flow cytometry in the study of platelets. Semin Hematol 2001, 38(2):160-168.
66. Schmitz G., Rothe G., Ruf A., et al. European Working Group on clinical cell analysis: consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 1998, 79:885-896.
67. Cardigan R., Turner C., Harrison P. Current methods of assessing platelet function: relevance to transfusion medicine. Vox Sang 2005, 88(3):153-163.
68. Favaloro E.J., Lippi G., Franchini M. Contemporary platelet function testing. Clin Chem Lab Med 2010, 48(5):579-598.
69. Michelson A.D., Barnard M.R., Krueger L.A., et al. Evaluation of platelet function by flow cytometry. Methods 2000, 21(3):259-270.
70. Bode A.P., Hickerson D.H. Characterization and quantitation by flow cytometry of membranous microparticles formed during activation of platelet suspensions with ionophore or thrombin. Platelets 2000, 11(5):259-271.
71. Kim H.K., Song K.S., Lee E.S., et al. Optimized flow cytometric assay for the measurement of platelet microparticles in plasma: pre-analytic and analytic considerations. Blood Coagul Fibrinolysis 2002, 13(5):393-397.
72. Macey M., McCarthy D., Azam U., et al. Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood. Cytometry B Clin Cytom 2003, 51(1):30-40.
73. Hu H., Daleskog M., Li N. Influences of fixatives on flow cytometric measurements of platelet P-selectin expression and fibrinogen binding. Thromb Res 2000, 100(3):161-166.
74. Ritchie J.L., Alexander H.D., Rea I.M. Flow cytometry analysis of platelet P-selectin expression in whole blood-methodological considerations. Clin Lab Haematol 2000, 22(6):359-363.
75. Derian C.K., Santulli R.J., Tomko K.A., et al. Species differences in platelet responses to thrombin and SFLLRN. Receptor-mediated calcium mobilization and aggregation, and regulation by protein kinases. Thromb Res 1995, 78(6):505-519.
76. Nylander S., Mattsson C., Lindahl T.L. Characterisation of species differences in the platelet ADP and thrombin response. Thromb Res 2006, 117(5):543-549.